US-based Bioage Labs’ lead medicine prospect, azelaprag, for the therapy of weight problems has a possibly hazardous negative effects.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/bioage-labs-stops-phase-2-trial-of-weight-loss-drug-stock-drops-76/